Jong Ho Moon

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Sang‐Heum Park · 2 shared papers, 2012–2022 · strength 0.17
   • Paper Modified non-flared fully covered self-expandable metal stent for preoperative biliary drainage in pancreatic cancer. DOI 10.1111/jgh.15733↗
   • Paper Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory p… DOI 10.3892/ol.2012.637↗
2. Seo‐Youn Choi · 1 shared paper, 2022 · strength 0.15
   • Paper Modified non-flared fully covered self-expandable metal stent for preoperative biliary drainage in pancreatic cancer. DOI 10.1111/jgh.15733↗
3. Il Sang Shin · 1 shared paper, 2022 · strength 0.15
   • Paper Modified non-flared fully covered self-expandable metal stent for preoperative biliary drainage in pancreatic cancer. DOI 10.1111/jgh.15733↗
4. Sung Hee Lim · 1 shared paper, 2021 · strength 0.11
   • Paper Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized … DOI 10.3349/ymj.2021.62.8.671↗
5. Min Jae Yang · 1 shared paper, 2017 · strength 0.06
   • Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008↗
6. Shin Il Kim · 1 shared paper, 2017 · strength 0.06
   • Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008↗
7. Jin‐Seok Park · 1 shared paper, 2017 · strength 0.06
   • Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008↗
8. Jin Hong Kim · 1 shared paper, 2017 · strength 0.06
   • Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008↗
9. Hyun Woo Lee · 1 shared paper, 2017 · strength 0.06
   • Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008↗
10. Don Haeng Lee · 1 shared paper, 2017 · strength 0.06
    • Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008↗
11. Chang‐Il Kwon · 1 shared paper, 2017 · strength 0.06
    • Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008↗
12. Seung Woo Park · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
13. Si Young Song · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
14. Hee Seung Lee · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
15. Chang Duck Kim · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
16. Moon Jae Chung · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
17. Dong Uk Kim · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
18. Jeong Youp Park · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
19. Sang Hyub Lee · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
20. Kwang Bum Cho · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
21. Ho Gak Kim · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
22. Young Koog Cheon · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
23. Ho Soon Choi · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
24. Dong Ki Lee · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
25. Yong‐Tae Kim · 1 shared paper, 2017 · strength 0.05
    • Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.